Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - IDENIX PHARMACEUTICALS INC | Financial_Report.xls |
| 10-K - FORM 10-K - IDENIX PHARMACEUTICALS INC | d299951d10k.htm |
| EX-31.2 - EXHIBIT 31.2 - IDENIX PHARMACEUTICALS INC | d299951dex312.htm |
| EX-32.1 - EXHIBIT 32.1 - IDENIX PHARMACEUTICALS INC | d299951dex321.htm |
| EX-31.1 - EXHIBIT 31.1 - IDENIX PHARMACEUTICALS INC | d299951dex311.htm |
| EX-32.2 - EXHIBIT 32.2 - IDENIX PHARMACEUTICALS INC | d299951dex322.htm |
| EX-10.12 - EXHIBIT 10.12 - IDENIX PHARMACEUTICALS INC | d299951dex1012.htm |
| EX-21.1 - EXHIBIT 21.1 - IDENIX PHARMACEUTICALS INC | d299951dex211.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File Nos. 333-118341, 333-128882, 333-143620 and 333-167330) and Form S-3 (File Nos. 333-127710, 333-129213, 333-153471, 333-159716, 333-173374 and 333-177167) of Idenix Pharmaceuticals, Inc. of our report dated March 6, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 6, 2012